Cite
Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.
MLA
Vos, Robin, et al. “Pirfenidone in Restrictive Allograft Syndrome after Lung Transplantation: A Case Series.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 18, no. 12, Dec. 2018, pp. 3045–59. EBSCOhost, https://doi.org/10.1111/ajt.15019.
APA
Vos, R., Wuyts, W. A., Gheysens, O., Goffin, K. E., Schaevers, V., Verleden, S. E., Van Herck, A., Sacreas, A., Heigl, T., McDonough, J. E., Yserbyt, J., Godinas, L., Dupont, L. J., Neyrinck, A. P., Van Raemdonck, D. E., Verbeken, E. K., Vanaudenaerde, B. M., & Verleden, G. M. (2018). Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 18(12), 3045–3059. https://doi.org/10.1111/ajt.15019
Chicago
Vos, Robin, Wim A Wuyts, Olivier Gheysens, Karolien E Goffin, Veronique Schaevers, Stijn E Verleden, Anke Van Herck, et al. 2018. “Pirfenidone in Restrictive Allograft Syndrome after Lung Transplantation: A Case Series.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 18 (12): 3045–59. doi:10.1111/ajt.15019.